Health and wellness payments for Pharmaceuticals.
Pharmaceutical companies operate under some of the strictest payment-compliance regimes in commerce.
Cardflo delivers regulated payment orchestration with specialist acquiring relationships that understand prescription drug sales (MCC 5912), DEA-controlled substance schedules, MHRA and FDA frameworks, robust fraud and age-verification controls, and audit-ready reporting for inspection-ready merchants.
- Industry
- Pharmaceuticals
- Category
- Health
- Cardflo support
- Yes
The overview
Pharmaceutical payment processing involves complex coordination. It includes regulatory frameworks, merchant category code (MCC) assignment, and risk management.
Transactions typically fall under MCC 5912. This concerns retail pharmacies.
Specialised codes are used for wholesale and telepharmacy. These businesses require acquirers that accept inherent risks.
They deal with prescription-only medicines (POM), over-the-counter products, and controlled substances. The payment stack must integrate age verification.
It also needs prescriber validation. This ensures compliance with the Medicines and Healthcare products Regulatory Agency (MHRA) or the Food and Drug Administration (FDA).
Data security must extend beyond PCI DSS. It must align with health-specific data privacy mandates.
Examples are HIPAA in the United States or the Data Protection Act in the United Kingdom. Robust gateway infrastructure ensures every authorisation.
Each undergoes rigorous fraud screening. This includes 3D Secure 2.
2 (3DS) and Address Verification Service (AVS) checks. This mitigates the risk of illegal distribution and representment challenges.
How it works
Merchant Onboarding and KYB
The process begins with rigorous Know Your Business (KYB) checks. Acquirers evaluate pharmacy licences. They check DEA registrations or MHRA certifications. This due diligence ensures the merchant is authorised. It allows them to dispense specific schedules of medication. The acquirer assigns the appropriate MCC. This could be 5912. It is based on the merchant's specific licence and delivery model.
Checkout and Age Verification
At the point of sale, the gateway triggers third-party services. These are for age and identity verification. This occurs before the authorisation request is sent to the issuer. If the consumer fails these checks, the transaction is terminated. This ensures compliance with laws. These laws govern the sale of restricted health products.
Authorisation and Fraud Screening
Transaction data is routed through a fraud engine. This engine prioritises SCA compliance and 3DS protocols. The system analyses factors. These include BIN location, IP address, and AVS data. Merchants often require network tokenisation. This secures cardholder data for recurring prescriptions. It also reduces the scope of PCI DSS audits.
Settlement and Audit Reporting
After successful authorisation and capture, funds are settled. They go into the merchant account. This often includes a rolling reserve. This manages higher chargeback risks in the sector. Detailed line-item reports are generated. These allow for reconciliation. Reconciliation happens between the payment gateway and pharmacy management software. This is for regulatory auditing.
Why it matters
Risk Mitigation and Compliance
Operating in the pharmaceutical sector without specialised payment infrastructure leads to high decline rates. It can also lead to potential account terminations. Card schemes view pharmacies as high-risk. This is due to regulatory volatility. Using specific MCC 5912 acquiring pathways helps. Robust 3DS implementations also help. Both protect the merchant's ability to process payments. They satisfy legal requirements of health regulators and card brands.
Operational Continuity for Patients
Payment failure can lead to health risks. This concerns patients relying on chronic medication. Payment orchestration allows for smart routing. It also uses account updaters. This ensures recurring prescription renewals are not interrupted. This avoids expired cards or false-positive fraud declines. This stability is critical for maintenance therapy. It is also critical for B2B wholesale supply chains. Large-value transactions must clear reliably in these cases.
Regulatory notes
Card Scheme Pharmacy Monitoring
Visa and Mastercard operate specific monitoring programmes for pharmacies. Merchants must register through their acquirers.
They may be subject to additional fees. Failure to comply with scheme rules can occur.
These rules concern illegal drug sales or cross-border shipping. This can result in immediate termination of processing privileges.
It can also lead to inclusion on the MATCH list.
PSD2 and Medical MITs
Under PSD2, recurring prescription payments are treated as Merchant-Initiated Transactions (MITs). These require an initial transaction.
This transaction needs Strong Customer Authentication. Subsequent payments can be processed without SCA.
This is provided they are correctly flagged. This happens in the authorisation message.
This ensures uninterrupted service for long-term health management.
Use cases
Online Pharmacy Portals
E-commerce platforms dispense prescription-only medicines. They need integrated prescriber validation. They also require identity checks. They need secure vaults for storing patient payment methods. This is for repeat prescriptions.
Wholesale Health Distribution
B2B distributors handle bulk pharmaceutical supplies. They require high-limit processing. They also need multi-currency settlement capabilities. This manages cross-border transacting. It occurs between manufacturers and retail chains.
Telehealth and Consultation Services
Services combine a medical consultation with a prescription. They require a split-payment or secondary authorisation model. This separates the professional service fee. It also separates the drug dispensing cost.
By the numbers
Most card schemes require pharmacies to maintain a certain ratio. This is a chargeback-to-transaction ratio. It must be below this threshold. This avoids entering high-risk monitoring programmes.
This is a typical improvement. It is observed when pharmacies switch gateways. They move from generic gateways to those using account updaters. They also use high-risk-optimised routing.
This is the standard duration for a 3DS2 challenge. It indicates the necessity of low-latency gateway infrastructure. This prevents patient checkout abandonment.
Related terms
Book a scoping call to see how Cardflo would set you up.
What's included.
- Specialist acquiring relationships for MCC 5912 and related medical supply merchant categories.
- Support for 3DS2 and Strong Customer Authentication to meet PSD2 and UK regulatory standards.
- Integrated age and identity verification services to automate compliance at the digital checkout.
- Network tokenisation for secure storage of patient credentials during long-term medication cycles.
- Comprehensive AVS and CVV matching to reduce the incidence of friendly fraud and disputes.
- Audit-ready reporting modules that simplify compliance for MHRA, FDA, and internal health audits.
- Account updater services to maintain continuity for subscription-based wellness and pharmacy plans.
- Multi-currency settlement options to facilitate cross-border B2B pharmaceutical trade and distribution.
- Advanced dispute management with templates tailored to pharmaceutical regulatory requirements and proof-of-delivery.
- High-capacity processing for large-ticket wholesale transactions with specialised risk profiling and monitoring.
Talk to an acquiring specialist about your MID setup.
Common questions.
Why is MCC 5912 considered high-risk by most merchant acquirers?
The pharmaceutical industry is categorised as high-risk primarily due to the complex legal landscape and the potential for regulatory fines. Card schemes like Visa and Mastercard impose strict monitoring programmes on pharmacies to prevent the sale of counterfeit drugs or unauthorised distribution across borders.
Additionally, the sector experiences a higher frequency of disputes regarding delivery and product efficacy. Consequently, acquirers require more extensive documentation, higher reserve amounts, and specialised fraud monitoring to mitigate these systemic risks.
How does 3D Secure 2.2 benefit an online pharmacy?
3D Secure 2. 2 provides a friction-minimised method to verify the cardholder's identity.
For pharmacies, this is vital for meeting Strong Customer Authentication (SCA) requirements while reducing shopping cart abandonment. By providing additional data points to the issuer, such as the shipping address and transaction history, the likelihood of a successful authorisation increases.
Crucially, it also facilitates a liability shift, protecting the pharmacy from certain types of fraudulent chargebacks when the transaction is successfully authenticated.
Can pharmaceutical merchants process cross-border payments for prescriptions?
Cross-border processing for prescriptions is highly restricted. Merchants must comply with the laws of both the originating and destination countries.
Most acquirers require the merchant to prove they are licensed to sell in every jurisdiction where they accept payments.
Payment gateways help manage this by utilising geo-blocking or smart-routing to ensure transactions only proceed when they meet the specific compliance criteria of the cardholder's region and the acquirer's risk appetite.
What is the role of an account updater in pharmacy subscriptions?
Many pharmacies move to a subscription model for chronic medications. If a patient's card expires or is replaced, the payment will fail, leading to a disruption in care.
An account updater service automatically communicates with the card schemes to retrieve new card details before the next billing cycle. This ensures the Merchant-Initiated Transaction (MIT) is successful, reducing dunning efforts and ensuring the patient receives their medication without delay.
How does tokenisation help with PCI DSS compliance for pharmacies?
Tokenisation replaces sensitive primary account numbers (PAN) with non-sensitive digital tokens. For pharmacies, this means that patient payment data is not stored on their local servers, significantly reducing the scope of their PCI DSS audit.
Since health organisations are also subject to strict data privacy laws like HIPAA, tokenisation adds a layer of security that ensures card data is decoupled from patient health records, minimising the impact of potential data breaches.
What documentation is required for a pharmacy to obtain a MID?
To obtain a Merchant Identification Number (MID) in the pharmaceutical sector, a business must typically provide its pharmacy licence, the pharmacist’s professional certification, and proof of registration with national bodies like the GPhC in the UK.
Acquirers also review the website’s terms and conditions, refund policies, and the presence of required regulatory stamps. A review of the supply chain and proof of partnership with licensed distributors is often necessary to satisfy AML and KYB requirements.
Related industries.
Related guides.
Ready for velocity?
Tell us about your business. We'll match you with the right acquiring partners and the right route, typically inside a week.